Literature DB >> 34078373

Translation and psychometric evaluation of the German version of the IcanSDM measure - a cross-sectional study among healthcare professionals.

Anja Lindig1,2, Pola Hahlweg3,4, Eva Christalle3,4, Anik Giguere5, Martin Härter3,4, Olaf von dem Knesebeck4,6, Isabelle Scholl3,4.   

Abstract

BACKGROUND: Shared decision-making (SDM) between patients and healthcare professionals (HCPs) is a key component of patient-centred care. To implement SDM in clinical practice and to evaluate its effects, it is helpful to know about HCPs' perception of SDM barriers. The measure IcanSDM was developed in Canada and assesses the perception of SDM barriers. To our knowledge, no equivalent measure exists in German. Therefore, the aim of this study was to translate and adapt the IcanSDM measure to be used by a German speaking population and evaluate its psychometric properties.
METHODS: This is a cross-sectional psychometric study based on a secondary analysis of baseline data from a SDM implementation study. The original 8-item IcanSDM was translated into German using a team translation protocol. We assessed comprehensibility via cognitive interviews with n = 11 HCPs. Based on results of cognitive interviews, the translated IcanSDM version was revised. Two hundred forty-two HCPs filled out the measure. Psychometric analysis included acceptance (completion rate), item characteristics (response distribution, skewness, item difficulties, corrected item-total correlations, inter-item correlations), factorial structure (confirmatory factor analysis (CFA), model fit), and internal consistency (Cronbach's α).
RESULTS: We translated and adapted the German IcanSDM successfully except for item 8, which had to be revised after the cognitive interviews. Completion rate was 98%. Skewness of the items ranged between -.797 and 1.25, item difficulties ranged between 21.63 and 70.85, corrected item-total-correlations ranged between .200 and .475, inter-item correlations ranged between .005 and .412. Different models based on CFA results did not provide a valid factorial structure. Cronbach's α ranged between .563 and .651 for different factor models.
CONCLUSION: We provide the first German measure for assessing perception of SDM barriers by HCPs. The German IcanSDM is a brief measure with good acceptance. However, we found unsatisfying psychometric properties, which were comparable to results of the original scale. In a next step, the IcanSDM should be further developed and modified and predictive validity should be evaluated.

Entities:  

Keywords:  Implementation; Measurement; Measuring attitudes regarding shared decision-making; Perspective of healthcare professionals; Psychometrics; Shared-decision making

Mesh:

Year:  2021        PMID: 34078373     DOI: 10.1186/s12913-021-06430-3

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  41 in total

Review 1.  [Patient involvement in medical decision making--an overview on patient preferences and impacting factors].

Authors:  J Ernst; E Brähler; G Weißflog
Journal:  Gesundheitswesen       Date:  2014-01-09

Review 2.  Outcome-Relevant Effects of Shared Decision Making.

Authors:  Katarina Hauser; Armin Koerfer; Kathrin Kuhr; Christian Albus; Stefan Herzig; Jan Matthes
Journal:  Dtsch Arztebl Int       Date:  2015-10-02       Impact factor: 5.594

3.  Shared Decision Making and the Use of Decision Aids.

Authors:  Martin Härter; Angela Buchholz; Jennifer Nicolai; Katrin Reuter; Fely Komarahadi; Levente Kriston; Birgit Kallinowski; Wolfgang Eich; Christiane Bieber
Journal:  Dtsch Arztebl Int       Date:  2015-10-02       Impact factor: 5.594

4.  Cancer patients' preferred and perceived level of involvement in treatment decision-making: an epidemiological study.

Authors:  Pola Hahlweg; Levente Kriston; Isabelle Scholl; Elmar Brähler; Hermann Faller; Holger Schulz; Joachim Weis; Uwe Koch; Karl Wegscheider; Anja Mehnert; Martin Härter
Journal:  Acta Oncol       Date:  2020-05-19       Impact factor: 4.089

5.  Patient participation and shared decision making in Germany - history, agents and current transfer to practice.

Authors:  Martin Härter; Hardy Müller; Jörg Dirmaier; Norbert Donner-Banzhoff; Christiane Bieber; Wolfgang Eich
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2011-05-04

Review 6.  Patient preferences for shared decisions: a systematic review.

Authors:  Betty Chewning; Carma L Bylund; Bupendra Shah; Neeraj K Arora; Jennifer A Gueguen; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2011-04-06

Review 7.  Assessments of the extent to which health-care providers involve patients in decision making: a systematic review of studies using the OPTION instrument.

Authors:  Nicolas Couët; Sophie Desroches; Hubert Robitaille; Hugues Vaillancourt; Annie Leblanc; Stéphane Turcotte; Glyn Elwyn; France Légaré
Journal:  Health Expect       Date:  2013-03-04       Impact factor: 3.377

8.  Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.

Authors:  Radoslav Chekerov; Philipp Harter; Stefan Fuxius; Lars Christian Hanker; Linn Woelber; Lothar Müller; Peter Klare; Wolfgang Abenhardt; Yoana Nedkova; Isil Yalcinkaya; Georg Heinrich; Harald Sommer; Sven Mahner; Pauline Wimberger; Dominique Koensgen-Mustea; Rolf Richter; Gülten Oskay-Oezcelik; Jalid Sehouli
Journal:  Gynecol Oncol Res Pract       Date:  2017-03-07

9.  Which Dimensions of Patient-Centeredness Matter? - Results of a Web-Based Expert Delphi Survey.

Authors:  Jördis M Zill; Isabelle Scholl; Martin Härter; Jörg Dirmaier
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 10.  Congruence between patients' preferred and perceived participation in medical decision-making: a review of the literature.

Authors:  Linda Brom; Wendy Hopmans; H Roeline W Pasman; Danielle R M Timmermans; Guy A M Widdershoven; Bregje D Onwuteaka-Philipsen
Journal:  BMC Med Inform Decis Mak       Date:  2014-04-03       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.